Research programme: PPAR-gamma agonists - Evolva Biotech
Latest Information Update: 22 Feb 2010
At a glance
- Originator Evolva Biotech
- Class Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor gamma agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 07 Mar 2007 Preclinical trials in Diabetes mellitus in Switzerland (unspecified route)